The below are links to details of introduction to trials and how to interpret trials. Lots of information and hard to understand some as its quite top level but worth
Conferences – UKBI May and November 2020
***SAVE THE DATES*** UK Breast Intergroup Meetings 1st May and 17th November 2020 Dear members, To help you plan your agenda for 2020, we would like to inform you that
The researchers who make a difference to MBC patients
We thought you would like to hear about what it is like to work in metastatic breast cancer research. Here, we chat to Dr Rachel Eyre who works at The
TotalHealth.Co.Uk: When breast cancer is incurable by @madmeynell
METUPUK Member and ‘Patient Expert’ Madeleine Meynell wrote this piece for Total Health: The signs and symptoms of metastatic breast cancer can be non-specific and mimic other conditions. A study by Breast
National Cancer Research Institute Conference #NCRI2019
Early start Sunday 3rd November off to Glasgow for a 3 days conference (see collected data on the NCRI page). The NCRI is the National Cancer Research Institute so it
Founder @abcdiagnosis appears on @thismorning discussing #EndOfTreatmentBells
Founder of METUP-UK Jo Taylor appeared on ITV This Morning, discussing ‘end of treatment bells’. Jo has written a piece for the British Medical Journal on this, which gives more insight
Secondary Breast Cancer Awareness Conference 2019 – Swansea
I was invited by Ann Baker to attend the Secondary Breast Cancer Awareness Conference 2019 in Swansea. Unbelievably she is the ONLY Clinical Nurse Specialist in Wales! It was a
Taking control after a secondary breast cancer diagnosis – what I wish I knew when I was first diagnosed
I was diagnosed with primary and secondary breast cancer in March 2015. The first couple of months were spent being directed by medical staff (they were amazing!). I had two
Member Beth Roberts explains METUPUK aims and infographics
METUPUK member Beth Roberts gives a really clear overview of the aims of METUPUK, and explains the importance of the red flag infographics, whilst attending an oncology conference as a